Trials / Completed
CompletedNCT00189722
Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy and safety of tacrolimus in patients with asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus |
Timeline
- Primary completion
- 2005-07-01
- Completion
- 2005-07-01
- First posted
- 2005-09-19
- Last updated
- 2008-04-17
Locations
28 sites across 5 countries: Czechia, Germany, Poland, Russia, Ukraine
Source: ClinicalTrials.gov record NCT00189722. Inclusion in this directory is not an endorsement.